Jeffrey Strawn, MD

Dr. Strawn is a tenured Professor of Psychiatry, Pediatrics, and Clinical Pharmacology at the University of Cincinnati and Cincinnati Children’s Hospital. He is the Director of the University of Cincinnati Anxiety Disorders Research Program and the Associate Vice Chair of Research in the Department of Psychiatry & Behavioral Neuroscience at the University of Cincinnati. In addition, he co-directs the Cincinnati Center for Clinical & Translational Science & Training.
After earning a bachelor’s degree in biology at the University of Kentucky and then his M.D. from the University of Cincinnati, Dr. Strawn completed general psychiatry residency training at the UC and a clinical fellowship in child and adolescent psychiatry at Cincinnati Children’s Hospital.
His research focuses on anxiety and related disorders and the pharmacologic treatment of these disorders. With his collaborators, Dr. Strawn uses neuroimaging, pharmacogenetics, and pharmacologic approaches to predict treatment response and medication tolerability. His work broadly aims to identify the best treatments for individual patients based on patient-specific characteristics and to characterize the trajectory of improvement. This work has provided a platform for refining treatment targets and identifying treatment response biomarkers in anxiety and related disorders.
Dr. Strawn is extensively involved in medical education. He is a highly sought-after speaker at both national and international meetings. In his clinical practice, he works with youth with anxiety and related disorders and their families and supervises residents and fellows. Dr. Strawn has authored some 200 peer-reviewed publications and co-authored three textbooks. He is a distinguished fellow of the American Academy of Child & Adolescent Psychiatry and has received multiple awards for teaching, mentorship and research.
Financial relationships
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:NIHDate added:09/06/2022Date updated:09/06/2022
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:PCORIDate added:09/06/2022Date updated:09/06/2022
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:Cerevel, Intracellular TherapeuticsTopic:consultantDate added:09/06/2022Date updated:09/06/2022
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:Medscape, Neuroscience Education InstituteTopic:speaker (CME)Date added:09/06/2022Date updated:09/06/2022
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:MyriadTopic:material supportDate added:09/06/2022Date updated:09/06/2022
-
Attribution:SelfType of financial relationship:CopyrightIneligible company:Springer, NEIDate added:09/06/2022Date updated:09/06/2022
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:AbbvieDate added:09/06/2022Date updated:09/06/2022
**Disclaimer**
This Continuing Medical Education (CME) Learning Management System, Ethos, includes individuals designated as 'faculty' for CME purposes. Please note that the term 'faculty' refers solely to their role as a contributor/planner within a CME activity and does not imply any formal affiliation with UT Southwestern Medical Center (UTSW). The display of names and credentials is intended for educational purposes only and does not necessarily indicate a professional or academic relationship with UTSW. Participants are encouraged to verify the affiliations and credentials of faculty members independently if further clarification is needed.

Facebook
X
LinkedIn
Forward